Clinical Trial: Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening

U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07314307) titled 'Vaccine Effectiveness of One Dose of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Young-adult Women in Sweden Among Women Participating in a Clinical Trial of Concomitant HPV Vaccination and Screening' on Sept. 10, 2025.

Brief Summary: This study aims to evaluate the vaccine effectiveness of 1 dose the nonavalent human papillomavirus (HPV) vaccine against HPV16, 18, 31, 33, 45, 52, and 58 infection among young adult women in Sweden participating in a nationwide HPV elimination trial.

Study Start Date: May 03, 2021

Study Type: INTERVENTIONAL

Condition: Incident HPV16, 18, 31, 33, 45, 52 or 58 Infection

Intervention: B...